Exposing Fetal Drug Exposure

被引：5

作者：

DeVane, L. ^{[1
]}

Goetzl, L. M. ^{[2
]}

Ramamoorthy, S. ^{[3
]}

机构：

[1] Med Univ S Carolina, Dept Psychiat, Charleston, SC 29425 USA

[2] Med Univ S Carolina, Dept Obstet & Gynecol, Charleston, SC 29425 USA

[3] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷 / 06期

关键词：

D O I：

10.1038/clpt.2011.67

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Pregnancy neither protects women from susceptibility to illness nor generally decreases drug dosage requirements of preexisting pharmacotherapy. Thus, a major concern of drug use during pregnancy is maintenance of maternal health while minimizing fetal drug exposure. Important assumptions in reproductive medicine are that fetal exposure to any medication can present risks in pregnancy-because not all risks are known, as little exposure as possible is desirable.

引用

页码：786 / 788

页数：3

共 50 条

[41] The contribution of fetal drug exposure to temperament: potential teratogenic effects on neuropsychiatric risk
Weiss, Sandra J.
Jonn-Seed, Mary St.
Harris-Muchell, Carolyn
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2007, 48 (08) : 773 - 784
[42] Fetal Antiepileptic Drug and Folate Exposure: Cognitive Outcomes at Age 6 Years
Meador, Kimford
Baker, Gus
Browning, Nancy
Cohen, Morris
Brombley, Rebecca
Clayton-Smith, Jill
Kalayjian, Laura
Kanner, Andres
Liporace, Joyce
Pennell, Page
Privitera, Michael
Loring, David
NEUROLOGY, 2012, 78
[43] Effect of fetal alcohol exposure on adult symptoms of nicotine, alcohol, and drug dependence
Yates, WR
Cadoret, RJ
Troughton, EP
Stewart, M
Giunta, TS
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1998, 22 (04) : 914 - 920
[44] Exposing drug industry funding of UK patient organisations
Ozieranski, Piotr
Rickard, Emily
Mulinari, Shai
BMJ-BRITISH MEDICAL JOURNAL, 2019, 365
[45] Exposing Clinicians to Exposure: A Randomized Controlled Dissemination Trial of Exposure Therapy for Anxiety Disorders
Harned, Melanie S.
Dimeff, Linda A.
Woodcock, Eric A.
Kelly, Tim
Zavertnik, Jake
Contreras, Ignacio
Danner, Sankirtana M.
BEHAVIOR THERAPY, 2014, 45 (06) : 731 - 744
[46] Predicting Human Fetal Drug Exposure Through Maternal-Fetal PBPK Modeling and In Vitro or Ex Vivo Studies
Balhara, Ankit
Kumar, Aditya R.
Unadkat, Jashvant D.
JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 : S94 - S114
[47] Infection and disruption of placental multidrug resistance (MDR) transporters: Implications for fetal drug exposure
Andrade, C. B. V.
Lopes, L. V. A.
Ortiga-Carvalho, T. M.
Matthews, S. G.
Bloise, E.
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2023, 459
[48] The fetal/child perspective - Risks related drug exposure of the child, breastfeeding and when to reassume
Hellwig, K.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 7 - 8
[49] Postnatal Metabolic and Reproductive Consequences of Fetal and Neonatal Exposure to the Smoking Cessation Drug Bupropion
De Long, Nicole
Hyslop, Jillian R.
Nicholson, Catherine J.
Morrison, Katherine M.
Gerstein, Hertzel C.
Holloway, Alison C.
REPRODUCTIVE SCIENCES, 2013, 20 (10) : 1156 - 1161
[50] Postnatal Reproductive Health Following Fetal and Neonatal Exposure to the Smoking Cessation Drug Bupropion
DeLong, N. E.
Poirier, B.
Hyslop, J. R.
Nicholson, C. J.
Morrison, K. M.
Gerstein, H. C.
Holloway, A. C.
JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, 2011, 2 : S6 - S6

← 1 2 3 4 5 →